These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6763002)

  • 21. BCG immunotherapy as an adjunct to chemotherapy in BL-lL patients--its effect on clinical regression, reaction severity, nerve function, lepromin conversion, bacterial/antigen clearance and 'persister' M. leprae.
    Shetty VP; Mistry NF; Wakade AV; Ghate SD; Capadia GD; Pai VV
    Lepr Rev; 2013 Mar; 84(1):23-40. PubMed ID: 23741880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG response to purified 65- and 70-kDa mycobacterial heat shock proteins and to antigen 85 in leprosy.
    Launois P; N'Diaye Niang M; Drowart A; Van Vooren JP; Sarthou JL; Lalu T; Millan J; Huygen K
    Int J Lepr Other Mycobact Dis; 1994 Mar; 62(1):48-54. PubMed ID: 8189089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The degradation of Mycobacterium leprae by a comparison of its staining properties.
    Ridley MJ
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):211-8. PubMed ID: 6194126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
    Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG
    Indian J Lepr; 1984; 56(4):764-75. PubMed ID: 6442720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation of M. leprae from human leproma and the development of a cytoplasmic skin test antigen from purified bacilli.
    Elliston EP; Taylor CE
    Int J Lepr Other Mycobact Dis; 1976; 44(3):319-31. PubMed ID: 789262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
    Ponnighaus JM; Fine PE
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals.
    Smelt AH; Rees RJ; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):501-6. PubMed ID: 7035030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae.
    Gill HK; Mustafa AS; Godal T
    Bull World Health Organ; 1986; 64(1):121-6. PubMed ID: 3524883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Assessment of the Mitsuda reaction in lepromatous patients inactive before and after immunotherapy].
    de Arruda MS; Fleury RN; Nogueira ME; Ura S; de Arruda OS
    Rev Soc Bras Med Trop; 1995; 28(3):233-6. PubMed ID: 7480918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility to leprosy may be conditioned by an interaction between the NRAMP1 promoter polymorphisms and the lepromin response.
    Ferreira FR; Goulart LR; Silva HD; Goulart IM
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):457-67. PubMed ID: 15755200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A follow-up study of multibacillary Hansen's disease patients treated with multidrug therapy (MDT) or MDT + immunotherapy (IMT).
    Rada E; Ulrich M; Aranzazu N; Rodriguez V; Centeno M; Gonzalez I; Santaella C; Rodriguez M; Convit J
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):320-7. PubMed ID: 9401484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM; Sampaio EP; de Moraes MO; Albuquerque EC; Castro AP; Sarno EN
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination and skin test studies on the children of leprosy patients.
    Stanford JL; Stanford CA; Ghazi Saidi K; Dowlati Y; Weiss SF; Farshchi Y; Madlener F; Rees RJ
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):38-44. PubMed ID: 2659700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
    Gill HK; Mustafa AS; Godal T
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pilot study to determine acceptability and ability of heat-killed Mycobacterium leprae plus BCG (HKML+BCG) vaccine to induce skin test conversion.
    Chen ZL; Tang QG; Wang ZM; Chen J
    Lepr Rev; 1993 Jun; 64(2):117-27. PubMed ID: 8341114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative leprosy vaccine trial in south India.
    Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J
    Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pilot study of three potential vaccines for leprosy in Bombay.
    Ganapati R; Revankar CR; Lockwood DN; Wilson RC; Price JE; Ashton P; Ashton LA; Holmes RM; Bennett C; Stanford JL
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):33-7. PubMed ID: 2659699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report.
    Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.